Viewing Study NCT00390468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-01-26 @ 6:47 AM
Study NCT ID: NCT00390468
Status: COMPLETED
Last Update Posted: 2014-05-28
First Post: 2006-10-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cancer View
None Pain View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tandutinib View
None MLN518 View
None CT53518 View
None pain View
None adenocarcinoma of the prostate View
None recurrent prostate cancer View
None stage IV prostate cancer View
None bone metastases View
None hormone-based castration View